Alan Barber. Professor of Clinical Neurology University of Auckland

Similar documents
Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland

Nicolas Bianchi M.D. May 15th, 2012

TIA Transient Ischaemic Attack?

Stroke/TIA. Tom Bedwell

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

Management of TIA. Dr Ali Ali Consultant Stroke and Geriatrics Royal Hallamshire Hospital

Vague Neurological Conditions

STROKE UPDATE ANTHEA PARRY MAY 2010

New Zealand Guideline for the Assessment and Management of Transient Ischaemic Attack (TIA) User Guide

CEREBRO VASCULAR ACCIDENTS

TIA: Updates and Management 2008

It s Always a Stroke; Except For When It s Not..

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

Stroke in the ED. Dr. William Whiteley. Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian

Stroke: clinical presentations, symptoms and signs

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11

PAPER F National Collaborating Centre for Chronic Conditions at the Royal College of Physicians

PFO closure group total no. PFO closure group no. of males

Acute stroke. Ischaemic stroke. Characteristics. Temporal classification. Clinical features. Interpretation of Emergency Head CT

Neurological Dilemmas in Primary Care

Aortic arch pathology. Cerebral ischemia following carotid artery stenosis.

Pre-Hospital Stroke Care: Bringing It To The Street. by Bob Atkins, NREMT-Paramedic AEMD EMS Director Bedford Regional Medical Center

Stroke School for Internists Part 1

Cerebrovascular Disease

E X P L A I N I N G STROKE

Appendix 2C - Stroke Services in Fife

Vascular Disorders. Nervous System Disorders (Part B-1) Module 8 -Chapter 14. Cerebrovascular disease S/S 1/9/2013

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Referral Guideline for Patients with TIA

Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

25/09/2018 HEADACHE. Dr Nick Pendleton

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

HEADACHE. Dr Nick Pendleton. September Headache

TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES

TIAs and posterior circulation problems

It is the nature of a stroke to partly take away the use of a man s limbs and to throw him onto the parish if he had no children to look to

There are several types of epilepsy. Each of them have different causes, symptoms and treatment.

Carotid Revascularization

Acute Stroke Management LUKE BRADBURY, MD 10/8/14 FALL WAPA CONFERENCE

How do we assess risk in TIA?

Acute Complications of Sickle Cell Disease Case Study 5 year old girl with Hemoglobin SS, weakness and slurred speech

Management of Acute Ischemic Stroke. Learning Objec=ves. What is a Stroke? Jen Simpson Neurohospitalist

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

a. Ischemic stroke An acute focal infarction of the brain or retina (and does not include anterior ischemic optic neuropathy (AION)).

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

Cerebral Vascular Diseases. Nabila Hamdi MD, PhD

2018 Early Management of Acute Ischemic Stroke Guidelines Update

GOVERNANCE BOARD. 14th January Clinical Audit of Stroke Services. At Shrewsbury and Telford Hospitals NHS Trust

How to Think like a Neurologist Review of Exam Process and Assessment Findings

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man

Stroke Mimics. Atlantic Canada Stroke Conference. Dr Warren Fieldus FRCP

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

P1: OTA/XYZ P2: ABC c01 BLBK231-Ginsberg December 23, :43 Printer Name: Yet to Come. Part 1. The Neurological Approach COPYRIGHTED MATERIAL

OVER- REACT. HOW MANY OF THE 10 STROKE SYMPTOMS DO YOU KNOW? Learn them inside > If you suspect STROKE, CALL 911 immediately

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Stroke Awareness. Presented by: Duane Anderson, MD Snoqualmie Valley Hospital Emergency Department Medical Director

STROKE INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:

Understanding Stroke

David Strain, Diabetes and Vascular Research Centre University of Exeter Medical School, UK

ICSS Safety Results NOT for PUBLICATION. June 2009 ICSS ICSS ICSS ICSS. International Carotid Stenting Study: Main Inclusion Criteria

Neurology Topics. Ian Rosemergy

TIA triage in Not all that glitters is gold

Neuropathology lecture series. III. Neuropathology of Cerebrovascular Disease. Physiology of cerebral blood flow

REFERRAL GUIDELINES VASCULAR SURGERY

Carotid Artery Surgery for the Prevention and Treatment of Ischemic Stroke Update 2015

Stroke Quality Measures. Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: May, 2012 Most recently updated: December 2012

Pharmacy STROKE. Anne Kinnear Lead Pharmacist NHS Lothian. Educational Solutions for Workforce Development

Recent Advances in Neurology Difficult Cases

Stroke: Every Minute Counts! Primary Stroke Center, Ingalls Memorial Hospital

Sex Differences in Stroke Risk and Quality of Life after Stroke

Critical Review Form Therapy

TCD in Subclavian Steal Syndrome

Disclosures. An Update on TIA and Minor Stroke. The Agenda PROGNOSIS PATHOPHYSIOLOGY GUIDELINES AND PROVEN MANAGEMENT STRATEGIES AGGRESSIVE TREATMENT

Thrombolysis for acute ischaemic stroke Rapid Assessment Protocol NORTHERN IRELAND Regional Protocol (Version 002 July 08)

Department Specific Guideline

Cryptogenic Strokes: Evaluation and Management

ESM 1. Survey questionnaire sent to French GPs. Correct answers are in bold. Part 2: Clinical cases: (Good answer are in bold) Clinical Case 1:

BY: Ramon Medina EMT-LP/RN

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for

IDPH EMS Region Five. Stroke Education

Faculty of Clinical Forensic Medicine Committee 1/2018

Current Clinical Trials for Stroke Survivors in NJ and Philadelphia Areas

Guideline scope Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (update)

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Oltre la terapia medica nelle dissezioni carotidee

Stroke Workshop. Pre-Workshop Handout. With Walter Himmel, Meeta Patel & Anton Helman

Variables in Riksstroke - TIA

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre

Document Title: The Management of Acute Ischemic Stroke & TIA

An Introduc+on to Stroke

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Transcription:

Alan Barber Professor of Clinical Neurology University of Auckland

Presented with L numbness & slurred speech 2 episodes; 10 mins & 2 hrs Hypertension Type II DM Examination P 80/min reg, BP 160/95, normal neurology

Diagnosed as TIA Discharged from hospital outpatient appointment at stroke clinic

Stroke

Loss of focal brain (or eye) function Of presumed vascular origin temporary loss of blood flow to brain/eye Symptoms resolve <24 hours Stroke

Loss of focal brain (or eye) function Of presumed vascular origin temporary loss of blood flow to brain/eye Symptoms resolve <24 hours A TIA is where stroke symptoms disappear within 24 hours Stroke

But

But most TIA s last only minutes 60% <1 hour 71% <2 hours 14% 2-24 hours

But 1/3 of TIA patients have acute cerebral infarction on MRI scans

Transient episode of neurological dysfunction caused by focal brain, spinal cord or retinal ischemia, without evidence of acute infarction

Transient episode of neurological dysfunction caused by focal brain, spinal cord or retinal ischemia, without evidence of acute infarction Tissue based definitions useful infarction distinguishes MI from angina focuses on pathophysiology, not temporal factors

An infarction of central nervous system tissue

TIAs don t precede cerebral hemorrhage don t cause loss of consciousness

TIAs don t precede cerebral hemorrhage don t cause loss of consciousness TIAs almost never cause isolated focal symptoms double vision or dysphagia non-focal symptoms faintness, dizziness, confusion

1 in 5 people with stroke had a TIA first

1 in 5 people with stroke had a TIA first The risk of stroke following a TIA is high

1 in 5 people with stroke had a TIA first The risk of stroke following a TIA is high Strokes after TIA are severe 1 in 5 fatal 2 in 3 survivors disabled

1 in 5 people with stroke had a TIA first The risk of stroke following a TIA is high Strokes after TIA are severe 1 in 5 fatal 2 in 3 survivors are disabled Not all TIAs carry the same stroke risk

Presented with L numbness & slurred speech 2 episodes; 10 mins & 2 hrs Hypertension Type II DM Examination P 80/min reg, BP 160/95, normal neurology

Age 60 1

Age 60 1 Blood pressure high 1

Age 60 1 Blood pressure high 1 Clinical no weakness 0 speech/no weakness 1 unilateral weakness 2

Age 60 1 Blood pressure high 1 Clinical no weakness 0 speech/no weakness 1 unilateral weakness 2 Duration <10 mins 0 10-59 mins 1 1 hour 2

Age 60 1 Blood pressure high 1 Clinical no weakness 0 speech/no weakness 1 unilateral weakness 2 Duration <10 mins 0 10-59 mins 1 1 hour 2 Diabetes 1

Presented with L numbness & slurred speech 2 episodes - 1 st 10 mins, 2 nd 2 hrs Hypertension Type II DM Examination normal but BP 160/95 ABCD2 = 6

25% 20% Stroke Risk 15% 10% 2-Day Risk 7-Day Risk 30-Day Risk 90-Day Risk 5% 0% 0 1 2 3 4 5 6 7 ABCD 2 Score

ABCD2 score: 0 3 4 5 6 7 Proportion of TIAs 34% 45% 21% Stroke risk at 2 days 1 4 8 7 days 1 6 12 3 months 3 10 18

As bad or worse than unstable angina Unstable angina 12% 30 day risk of death or MI Lancet 2002;359:189-98

80% of strokes after TIA can be prevented start aspirin (or clopidogrel) straight away blood pressure lowering therapy cholesterol lowering therapy stop smoking urgent carotid revascularisation

Discharged from hospital no change to usual aspirin outpatient appointment at stroke clinic Represented 4 days later with severe stroke left hemiparesis, sensory loss and neglect

Patients who need to be seen urgently ABCD 2 4 ABCD 2 <4 and In atrial fibrillation On an anti-coagulant Crescendo (recurrent TIAs) Patients who don t need to be seen urgently ABCD 2 <4 TIA more than a week ago ABCD 2 no good for posterior circulation

Patients who need to be seen urgently ABCD 2 4 ABCD 2 <4 and In atrial fibrillation On an anti-coagulant Crescendo (recurrent TIAs) Patients who don t need to be seen urgently ABCD 2 <4 TIA more than a week ago n

Patients who need to be seen urgently ABCD 2 4 ABCD 2 <4 and In atrial fibrillation On an anti-coagulant Crescendo (recurrent TIAs) Patients who don t need to be seen urgently ABCD 2 <4 TIA more than a week ago ABCD 2 no good for posterior circulation

Dr Anna Ranta, MD, FRACP on behalf of the FASTEST Trial Team

In primary care, an electronic decision support tool Improved guideline adherence Reduced 90 day stroke risk Reduced treatment costs without affecting safety A Ranta Neurology 2015

R weakness lasting <10 mins Past history nil / no meds never smoked Diagnosed TIA

Age 60 1 Blood pressure high 1 Clinical no weakness 0 speech/no weakness 1 unilateral weakness 2 Duration <10 mins 0 10-59 mins 1 1 hour 2 Diabetes 1

R weakness lasting <10 mins Past history nil / no meds never smoked ABCD2 = 2 3% three month stroke risk

R weakness lasting <10 mins Past history nil / no meds never smoked ABCD2 = 2 3% three month stroke risk No meds started & referred to outpatients

Admitted 3 days later slurred speech R face, arm and leg weakness BP 220/120 L subcortical infarct

We recommend sending patients to ED if ABCD 2 4 ABCD 2 <4 and In atrial fibrillation On an anti-coagulant Crescendo (recurrent TIAs)

But ABCD 2 = 2 patient still at risk for stroke (1 in 33)

But ABCD 2 = 2 patient still at risk for stroke (1 in 33) Before they leave start secondary prevention aspirin or clopidogrel anti-hypertensive lipid lowering therapy

Successive days had transient (10-15 mins) right amaurosis fugax left hand weakness one episode of right leg weakness Hypertensive, cholesterol, ex smoker R carotid bruit & normal neuro examination

Age 60 1 Blood pressure high 1 Clinical no weakness 0 speech/no weakness 1 unilateral weakness 2 Duration <10 mins 0 10-59 mins 1 1 hour 2 Diabetes 1 10% three month stroke risk

Successive days had transient (10-15 mins) right amaurosis fugax left hand weakness one episode of right leg weakness Hypertensive, cholesterol, ex smoker R carotid bruit & normal neuro examination Started aspirin & sent in

CT head normal Carotid US >70% right ICA stenosis L ICA occlusion Management iv heparin urgent carotid endarterectomy no further events

Send people to ED if recurrent TIAs regardless of ABCD 2 iv heparin often used with crescendo TIAs Urgent carotid US for people with carotid territory TIAs most benefit of carotid revascularisation in 1 st days after a TIA or minor stroke

Send people to ED if recurrent TIAs regardless of ABCD 2 iv heparin often used with crescendo TIAs Urgent carotid US for people with carotid territory TIAs most benefit of carotid revascularisation in 1 st days after a TIA or minor stroke What was the cause of right leg weakness?

Presented with slurred speech resolved after 1 h very mild L leg weakness (persisting when seen) Background HT dyslipidaemia TIA diagnosed & aspirin started

Admitted 3 weeks later headache L leg heavy and dragging Examination mild left arm & leg incoordination

It s not a TIA if neurological symptoms & signs when you see them TIA patients need brain imaging

Presented with left sided tongue numbness & tingling numbness slowly spread over 10 mins left mouth, face, upper limb & lower limb left upper & lower limbs felt heavy Background Nil Oral contraceptive

Examination Alert and oriented left facial, arm & leg sensory loss 4+/5 weakness left upper & lower limbs Investigations ECG normal Bloods normal

What s going on?

What s going on? Migraine

What s going on? Migraine Had low grade left-sided pressure that she hadn t commented on until asked Nothing to suggest previous migraine No family history of migraine Started Amitriptyline increasing to 75 mg at night

Tingling is a positive symptom should prompt consideration of migraine or sensory seizures Sensory march of symptoms over minutes typical for migraine Headache in migraine can be subtle

Presented with multiple episodes of L arm weakness L face and hand numbness/tingling lasting 20 mins Hypertensive Normal examination Multiple TIAs

Age 60 1 Blood pressure high 1 Clinical no weakness 0 speech/no weakness 1 unilateral weakness 2 Duration <10 mins 0 10-59 mins 1 1 hour 2 Diabetes 1 10% three month stroke risk

What s going on?

What s going on? Subarachnoid blood Sensory seizures Episodes stopped on phenytoin

Tingling is a positive symptom should prompt consideration of migraine or sensory seizures

Recurrent thunderclap headaches Recurrent episodes of ataxia bilateral LL weakness & sensory loss visual blurring Fluoxetine for depression Daily cannabis use

Admission

Admission 6 weeks later

94% thunderclap headaches 22% cortical SAH 16% TIA 4% stroke 6% intracerebral hemorrhage 3% seizures Ducros A. Brain;2007;130:3091

RCVS 37% spontaneous 7% post partum 55% vasoactive substances cannabis 30% SSRI 19% decongestants 12% cocaine 5% Ducros A. Brain;2007;130:3091

Presented (while driving) with Left upper limb fat & heavy Had to steer with right hand Then involuntary jerking left arm over 45 mins No alteration of awareness or other symptoms

Left parietal infarct at 30 years Left MCA TIA 2008 normal carotid ultrasound scan Smoker Migraine

What s going on?

What s going on? Focal onset seizures

What s going on? Focal onset seizures What do you do?

What s going on? Focal onset seizures What do you do? Lamotrigine; increasing to 100 mg BD Driving restriction

6x episodes over 4 weeks L upper & lower limb shaking when standing or walking eased if lay down Background R MCA infarct at 34 years Occluded R ICA Hypertensive, elevated lipids, smoker

L & R ICA systems separate with no Circle of Willis flow R ICA occluded R CCA stensosed L ICA patent

Jerky, coarse, involuntary movements upper +/- lower limbs multiple episodes last < 5 minutes precipitated by rising, exercising, coughing often accompanied by paresis 10% of patients with ICA occlusion Persoon S. Brain;2010;133:915

Due to low cerebral blood flow Not recurrent emboli epileptic no change level of consciousness face & trunk spared no Jacksonian march normal EEG Persoon S. Brain;2010;133:915

L & R ICA systems separate with no Circle of Willis flow R ICA occluded R CCA stensosed L ICA patent R CCA stented

TIAs precede ¼ strokes carry a poor prognosis up to 80% of strokes can be prevented stroke risk can be determined by ABCD2 score